v3.26.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Accounting Policies [Abstract]    
Schedule of assets measured at fair value on a recurring basis
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2026 and December 31, 2025 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine the fair value (in thousands):
 
     Fair value measurement at reporting date using  
      Level 1        Level 2        Level 3   
September 30, 2026
 
Assets:
        
Money market funds
   $ 29,722      $ —       $ —   
  
 
 
    
 
 
    
 
 
 
Total assets
   $ 29,722      $ —       $ —   
  
 
 
    
 
 
    
 
 
 
December 31, 2025
 
Assets:
        
Money market funds
   $ 15,367      $ —       $ —   
  
 
 
    
 
 
    
 
 
 
Total assets
   $ 15,367      $ —       $ —   
  
 
 
    
 
 
    
 
 
 
Assets measured at fair value on a recurring basis at December 31, 2025, are summarized below:
 
     Fair value measurement at reporting date using  
December 31, 2025    (Level 1)      (Level 2)      (Level 3)  
Assets:
        
Money market account
     $15,366,611        —         —   
Assets measured at fair value at December 31, 2024, are summarized below:
 
     Fair value measurement at reporting date using  
December 31, 2024    (Level 1)      (Level 2)      (Level 3)  
Assets:
        
Money market account
   $ 24,498,933        —         —   
Schedule of property plant and equipment estimated useful lives  
Estimated useful lives are as follows:
 
Category
  
Term
Laptops and IT equipment    3 years
Software purchase (excluding subscription)    3 years
Lab equipment    5 years
Furniture and fixtures    7 years
Leasehold improvements    Shorter of the remaining lease term or the estimated useful lives of the improvements
Schedule of diluted and basic net loss per share are identical for all periods presented   Accordingly, diluted net loss per share is the same as basic net loss per share for all periods presented:
 
    
Years Ended December 31,
 
    
2025
    
2024
 
Preferred stock
     2,488,103        2,488,103  
Stock options
     718,094        680,304  
  
 
 
    
 
 
 
Total anti-dilutive shares
     3,206,197        3,168,407  
  
 
 
    
 
 
 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive securities, presented on a recast basis, were excluded from the computation of diluted net loss per share because their effect would have been anti-dilutive:
 
 
  
As of September 30,
 
 
  
2026
 
  
2025
 
Convertible preferred stock (as converted at the Exchange Ratio)
  
 
—
 
 
  
 
2,488,103
 
Warrants
  
 
101,619
 
   — 
Stock options
  
 
1,155,632
 
  
 
638,879
 
Unvested restricted stock awards
  
 
524,828
 
  
 
138,113
 
  
 
 
    
 
 
 
Total anti-dilutive shares
  
 
1,782,079
 
  
 
3,265,095